Neo-adjuvant M-VAC chemotherapy trials in transitional cell carcinoma: perspectives for first line chemotherapy.
Sternberg
C N
CN
Memorial Sloan-Kettering Cancer Center, New York, New York.
Yagoda
A
A
Scher
H I
HI
Whitmore
W F
WF
Herr
H W
HW
Morse
M J
MJ
Sogani
P C
PC
Bosl
G
G
Watson
R C
RC
Hollander
P S
PS
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000628:therapy; D002945:Cisplatin / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D011300:Preoperative Care; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000628:therapy; D014747:Vinblastine / Q000008:administration & dosage
D014747:Vinblastine; D004317:Doxorubicin; D002945:Cisplatin; D008727:Methotrexate